Search

everythinglearnresearchcommunity

for

Search:↓

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

The new compound may be a safer alternative to finasteride for prostate protection.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Certain 4-azasteroids are effective at blocking the enzyme that processes testosterone in human skin and could help treat acne, excessive hair growth, and male pattern baldness.

The document explains how to make a compound called 3.BETA.-Benzoyloxy-4-pregnen-16.ALPHA.,17.ALPHA.-epoxy-6,20-dione and describes its crystal structure.

Researchers successfully made new compounds for hormone level tests, but one attempt led to an unexpected product, correcting a past error.

Testosterone with dutasteride improves muscle strength and body composition in trans men.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

The method produces finasteride with a 92% yield.

Certain Dibenzo derivatives may help treat prostate cancer.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

Scientists found new nonsteroidal compounds that can act like natural male hormones and might help treat male fertility and hormone issues.

Androsterone and finasteride have different solid forms, with new findings correcting previous errors and identifying a new form.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

The compounds tested could potentially treat hair loss and alopecia.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

The new delivery method for dutasteride is more effective and has fewer side effects.

The document's conclusion cannot be provided because the document is not available or cannot be read.

Prostate cells have proteins that bind to specific hormones, which can increase protein production when activated by these hormones.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.